EPA significantly improves anti-EGFR targeted therapy by regulating miR-378 expression in colorectal cancer

about

EPA significantly improves anti-EGFR targeted therapy by regulating miR-378 expression in colorectal cancer

Item

http://www.wikidata.org/entity/Q58573219

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

EPA significantly improves ant ...... xpression in colorectal cancer

@en

EPA significantly improves ant ...... xpression in colorectal cancer

@nl

type

Item

label

EPA significantly improves ant ...... xpression in colorectal cancer

@en

EPA significantly improves ant ...... xpression in colorectal cancer

@nl

prefLabel

EPA significantly improves ant ...... xpression in colorectal cancer

@en

EPA significantly improves ant ...... xpression in colorectal cancer

@nl

P1476

EPA significantly improves ant ...... xpression in colorectal cancer

@en

P2093

Hsi-Hsien Hsu

http://www.w3.org/2001/XMLSchema#string

Li-Wei Kuo

http://www.w3.org/2001/XMLSchema#string

Wai-Hung Leung

http://www.w3.org/2001/XMLSchema#string

Wen-Hui Weng

http://www.w3.org/2001/XMLSchema#string

Yeu Jye Pang

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Clinicopathological relevance of BRAF mutations in human cancer

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.

BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

RAF protein-serine/threonine kinases: structure and regulation

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma

P304

6188-6194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.9408

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30333883

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

cancer research

P932

6176383

http://www.w3.org/2001/XMLSchema#string